Neurocrine Biosciences logo

Neurocrine Biosciences Share Price (NASDAQ: NBIX)

$136.93

2.94

(2.19%)

Last updated on

Check the interactive Neurocrine Biosciences Stock chart to analyse performance

Neurocrine Biosciences stock performance

as on August 27, 2025 at 1:29 AM IST

  • Today's Low:$134.41
    Today's High:$136.98

    Day's Volatility :1.88%

  • 52 Weeks Low:$84.23
    52 Weeks High:$154.61

    52 Weeks Volatility :45.52%

Neurocrine Biosciences Stock Returns

PeriodNeurocrine Biosciences Inc.Sector (Health Care)Index (Russel 2000)
3 Months
8.94%
4.5%
0.0%
6 Months
13.99%
-7.9%
0.0%
1 Year
-12.14%
-12.3%
0.0%
3 Years
27.26%
7.0%
-6.9%

Neurocrine Biosciences Inc. Key Stats

Check Neurocrine Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$133.99
Open
$134.405
Today's High
$136.98
Today's Low
$134.405
Market Capitalization
$13.3B
Today's Volume
$530.2K
52 Week High
$154.61
52 Week Low
$84.23
Revenue TTM
$2.5B
EBITDA
$527.6M
Earnings Per Share (EPS)
$3.39
PE Ratio
39.53
Profit Margin
13.88%
Quarterly Earnings Growth YOY
0.68%
Return On Equity TTM
13.39%

Stock Returns calculator for Neurocrine Biosciences Stock including INR - Dollar returns

The Neurocrine Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neurocrine Biosciences investment value today

Current value as on today

₹94,453

Returns

₹5,547

(-5.55%)

Returns from Neurocrine Biosciences Stock

₹10,074 (-10.07%)

Dollar Returns*

₹4,527 (+4.53%)

Indian investors sentiment towards Neurocrine Biosciences Stock

17%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Neurocrine Biosciences Stock from India on INDmoney has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Neurocrine Biosciences Inc.

  • Name

    Holdings %

  • BlackRock Inc

    14.80%

  • Vanguard Group Inc

    9.89%

  • Dodge & Cox

    5.61%

  • State Street Corp

    4.90%

  • T. Rowe Price Associates, Inc.

    3.11%

  • JPMorgan Chase & Co

    2.69%

Analyst Recommendation on Neurocrine Biosciences Stock

Rating
Trend

Buy

    76%Buy

    23%Hold

    0%Sell

Based on 34 Wall street analysts offering stock ratings for Neurocrine Biosciences(by analysts ranked 0 to 5 stars)

Neurocrine Biosciences Share Price Target

What analysts predicted

Upside of 22.59%

Target:

$167.87

Current:

$136.93

Neurocrine Biosciences share price target is $167.87, a slight Upside of 22.59% compared to current price of $136.93 as per analysts' prediction.

Neurocrine Biosciences Stock Insights

  • Price Movement

    In the last 6 months, NBIX stock has moved up by 14.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 572.6M → 687.5M (in $), with an average increase of 16.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 7.9M → 107.5M (in $), with an average increase of 92.7% per quarter
  • NBIX vs HLN (1 yr)

    In the last 1 year, Neurocrine Biosciences Inc. has experienced a drawdown of -12.0%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 10.0%
  • NBIX vs HLN (3 yr)

    In the last 3 years, Haleon Plc Spon Ads has given 55.2% return, outperforming this stock by 27.4%
  • Price to Sales

    ForNBIX every $1 of sales, investors are willing to pay $5.4, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Neurocrine Biosciences Inc. Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$2.4B
↑ 24.81%
Net Income
$341.3M
↑ 36.68%
Net Profit Margin
14.49%
↑ 1.26%

Neurocrine Biosciences Technicals Summary

Sell

Neutral

Buy

Neurocrine Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Neurocrine Biosciences Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Neurocrine Biosciences Inc. logo
0.24%
13.99%
-12.14%
27.26%
17.25%
Haleon Plc Spon Ads logo
-0.31%
-5.2%
-3.01%
59.31%
30.5%
United Therapeutics Corporation logo
2.4%
-4.26%
-12.58%
40.37%
71.69%
Zoetis Inc. logo
2.91%
-5.98%
-14.81%
-1.74%
-3.04%

About Neurocrine Biosciences Inc.

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Organization
Neurocrine Biosciences
Employees
1800
CEO
Mr. Kyle W. Gano Ph.D.
Industry
Health Technology

Key Management of Neurocrine Biosciences Inc.

NameTitle
Mr. Kyle W. Gano Ph.D.
CEO & Director
Mr. Matthew C. Abernethy CPA
Chief Financial Officer
Dr. Jude Onyia Ph.D.
Chief Scientific Officer
Mr. Eric S. Benevich
Chief Commercial Officer
Dr. Eiry Wyn Roberts M.D.
Strategic Advisor
Dr. Wylie W. Vale Ph.D.
Co-Founder
Dr. Lawrence Steinman BA, M.D., Ph.D.
Co-Founder of Neurocrine
Mr. Lewis Choi
Chief Information Officer
Jane Sorensen
Head of Investor Relations
Mr. Darin M. Lippoldt Esq.
Chief Legal Officer & Corporate Secretary

Important FAQs about investing in NBIX Stock from India :

What is Neurocrine Biosciences share price today?

Neurocrine Biosciences share price today is $136.93 as on at the close of the market. Neurocrine Biosciences share today touched a day high of $136.98 and a low of $134.41.

What is the 52 week high and 52 week low for Neurocrine Biosciences share?

Neurocrine Biosciences share touched a 52 week high of $154.61 and a 52 week low of $84.23. Neurocrine Biosciences stock price today i.e. is closed at $136.93, lower by 11.44% versus the 52 week high.

How to invest in Neurocrine Biosciences Stock (NBIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neurocrine Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurocrine Biosciences Shares that will get you 0.0110 shares as per Neurocrine Biosciences share price of $136.93 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Neurocrine Biosciences Stock (NBIX) from India?

Indian investors can start investing in Neurocrine Biosciences (NBIX) shares with as little as ₹87.6525 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Neurocrine Biosciences stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Neurocrine Biosciences share’s latest price of $136.93 as on August 27, 2025 at 1:29 AM IST, you will get 0.0730 shares of Neurocrine Biosciences. Learn more about fractional shares .

What are the returns that Neurocrine Biosciences has given to Indian investors in the last 5 years?

Neurocrine Biosciences stock has given 17.25% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More